🇪🇺 LY03005 extended-release tablet in European Union

EMA authorised LY03005 extended-release tablet on 31 December 2009

Marketing authorisation

EMA — authorised 31 December 2009

  • Application: EMEA/H/C/000794
  • Marketing authorisation holder: Wyeth Europe Ltd.
  • Local brand name: Pristiqs
  • Status: withdrawn

Read official source →

Other Psychiatry/Neurology approved in European Union

Frequently asked questions

Is LY03005 extended-release tablet approved in European Union?

Yes. EMA authorised it on 31 December 2009.

Who is the marketing authorisation holder for LY03005 extended-release tablet in European Union?

Wyeth Europe Ltd. holds the EU marketing authorisation.